Parcrest Advises Medical Simulation Corporation on the Sale of its Medical Products Division to Mentice
DENVER, GOTHENBURG, Sweden and NEW YORK, Dec. 21, 2017 /PRNewswire/ -- The principals of Parcrest Advisors ("Parcrest") have acted as the exclusive investment banking advisors to Medical Simulation Corporation on the strategic cross-border sale of its Medical Products division ("MSC") to Mentice AB ("Mentice").
The transaction will create the world's most advanced endovascular medical simulation technology company, with a global client base in both blue chip medical device companies and renowned teaching hospitals.
Based in Denver, Colorado, MSC's simulation products help improve patient outcomes, reduce patient mortality, and lower the cost of healthcare delivery. Mentice is a Sweden-based global market leader in the medical simulation market with cutting-edge technology backed by 40 patents (representing the world's largest medical simulation patent portfolio) and 120+ scientific papers.
"We truly enjoyed working with John Z. Fang and James C. Lee of Parcrest Advisors in consummating this strategic sale," said Mary Beth Loesch, CEO of MSC. "Given their extensive cross-border experience in simulation technology, we could not have been better advised."
"Medical simulation is a multibillion dollar global market with tremendous growth potential. Thousands of lives will be saved as this technology is used to train medical practitioners," said John Z. Fang, Co-Founder and Partner of Parcrest. "We were glad to advise MSC on its transaction with Mentice and will build upon this deal and our principals' previous experience in advising Simbionix on its merger with 3D Systems to continue our track record as a leading investment banking boutique in the field of simulation technology."
About MSC
Medical Simulation Corporation is a global healthcare leader providing education services, including consulting, online courseware and simulation training in areas that are most impactful to hospitals and their patients such as sepsis and stroke. MSC's Advanced Clinical Quality Solutions enable multi-disciplinary healthcare team performance improvement with a focus on standardizing care delivery and creating clinical and cost-control results. MSC's education offerings are customized to meet the needs and challenges hospitals face daily, creating success by improving patient outcomes, decreasing patient mortality and reducing cost of healthcare delivery. www.medsimulation.com
About Mentice
Mentice is a leader in virtual reality?based interventional medical simulation solutions. Its solutions help healthcare professionals with skills acquisition, continuous development and preprocedural planning--leading to improved productivity and outcomes. Mentice solutions are scientifically validated, and have been specifically developed for healthcare providers and the medical industry. www.mentice.com
About Parcrest Advisors
Parcrest Advisors is a multidisciplinary cross-border investment bank based in New York City. In order to provide securities-related services discussed herein, certain principals of Parcrest are licensed with Burch & Company, Inc. member FINRA & SiPC. Burch & Company and Parcrest are not affiliated entities. Further information about Parcrest is available at www.parcrest.com.
View original content:http://www.prnewswire.com/news-releases/parcrest-advises-medical-simulation-corporation-on-the-sale-of-its-medical-products-division-to-mentice-300574724.html
SOURCE Parcrest Advisors
